Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Motif Bio Plc stock logo
MTFB
Motif Bio
$0.11
$0.10
$0.08
$11.50
N/AN/AN/A867,698 shs
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
$0.08
$0.08
$0.05
$0.35
N/A25.25N/AN/A
TRPX
Therapix Biosciences
$0.10
$0.23
$0.25
$4.69
$351KN/A1.59 million shs95,212 shs
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
$0.59
+19.3%
$0.53
$0.07
$1.45
$285.96M1.77141,517 shs2.07 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Motif Bio Plc stock logo
MTFB
Motif Bio
0.00%0.00%0.00%0.00%0.00%
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
0.00%0.00%0.00%0.00%+79,900.00%
TRPX
Therapix Biosciences
0.00%0.00%0.00%0.00%0.00%
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
+19.27%+33.33%+20.95%+36.74%-59.73%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Motif Bio Plc stock logo
MTFB
Motif Bio
N/AN/AN/AN/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Motif Bio Plc stock logo
MTFB
Motif Bio
0.00
N/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
0.00
N/AN/AN/A
TRPX
Therapix Biosciences
0.00
N/AN/AN/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Motif Bio Plc stock logo
MTFB
Motif Bio
N/AN/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/AN/AN/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
N/AN/AN/AN/A$0.03 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Motif Bio Plc stock logo
MTFB
Motif Bio
N/AN/A0.00N/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/A0.00N/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
-$4.79MN/A0.00N/AN/AN/AN/AN/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
-$3.45M-$0.33N/AN/AN/AN/AN/A-85.32%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Motif Bio Plc stock logo
MTFB
Motif Bio
N/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/AN/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Motif Bio Plc stock logo
MTFB
Motif Bio
N/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/A
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
N/A
1.13
1.13
CompanyEmployeesShares OutstandingFree FloatOptionable
Motif Bio Plc stock logo
MTFB
Motif Bio
7N/AN/ANot Optionable
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
51N/AN/ANot Optionable
TRPX
Therapix Biosciences
93.51 millionN/ANot Optionable
Mawson Infrastructure Group Inc. stock logo
WIZP
Mawson Infrastructure Group
2486.32 millionN/ANot Optionable

Recent News About These Companies

Mawson Infrastructure releases 2025 company presentation
Mawson Infrastructure names William Regan as CFO
Mawson Infrastructure reports December revenue $5.26M, up 7% month/month
Mawson Infrastructure executes new customer agreement
Motif Bio stock logo

Motif Bio NASDAQ:MTFB

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Parnell Pharmaceuticals stock logo

Parnell Pharmaceuticals OTCMKTS:PARNF

$0.08 0.00 (0.00%)
As of 04/22/2025

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Mawson Infrastructure Group stock logo

Mawson Infrastructure Group OTCMKTS:WIZP

$0.59 +0.10 (+19.27%)
As of 07/10/2025

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company is headquartered in North Sydney, Australia.